PROVECTUS BIOPHARMACEUTICALS, INC.·4

Dec 4, 7:52 PM ET

Rodrigues Dominic 4

4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Dec 4, 2024

Insider Transaction Report

Form 4
Period: 2024-12-02
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-12-02+16,146,60016,146,600 total
    Exercise: $0.29Exp: 2034-12-02Common Stock (16,146,600 underlying)
Footnotes (1)
  • [F1]The options vest in three equal annual installments beginning on December 2, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary